<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00235716</url>
  </required_header>
  <id_info>
    <org_study_id>546</org_study_id>
    <nct_id>NCT00235716</nct_id>
  </id_info>
  <brief_title>A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease</brief_title>
  <acronym>TEAM-AD</acronym>
  <official_title>CSP #546 - A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease (TEAM-AD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Forest Laboratories</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>DSM Nutritional Products, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether alpha-tocopherol, memantine (Namenda), or
      the combination will significantly delay clinical progression in mild to moderately demented
      patients with Alzheimer's disease compared to placebo.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Abstract: Alzheimer's disease (AD), a neurodegenerative disorder resulting in cognitive loss,
      behavioral problems, and functional decline, is characterized by well-established and
      well-known neuropathological changes in the brain. Cognitive deficits and behavioral symptoms
      are thought to be due to cholinergic neuronal degeneration and loss associated with oxidative
      stress and inflammatory responses.

      Current therapeutic strategies include efforts to

        1. enhance cholinergic neuronal function,

        2. promote neuroprotective effects, and

        3. block pathologic activity of excessive glutamate with a moderate-affinity NMDA
           antagonist.

      A combination of pharmacological therapies directed at simultaneously improving neuronal
      function and neuroprotection would presumably be more effective than either treatment alone.

      To test this hypothesis, this study will examine the efficacy of drug treatment with a
      combination of

        1. any of three FDA approved cholinesterase inhibitors that facilitates central
           acetylcholine neurotransmission (donepezil, rivastigmine, galantamine);

        2. alpha-tocopherol, a fat soluble vitamin that has been shown to slow the rate of
           progression of AD, presumably through neuroprotective mechanism that reduces oxidative
           stress; and

        3. memantine, a moderate-affinity NMDA antagonist that blocks excessive stimulation of NMDA
           receptors by glutamate. CSP#546 will be a double-blind, placebo-controlled, randomized,
           clinical trial to assess the efficacy of adding alpha-tocopherol, memantine, and the
           combination for the treatment of functional decline in mild-to-moderately demented
           patients with Alzheimer's disease (MMSE 12-26) who are currently taking an
           acetylcholinesterase inhibitor (AchEI).

      Eligible Veterans will be randomly assigned to either

        1. 2,000 IU/d of alpha-tocopherol plus memantine placebo,

        2. 20 mg/d of memantine (Namenda) plus alpha-tocopherol placebo,

        3. 2,000 IU/d of alpha-tocopherol plus 20 mg/d of memantine, or

        4. alpha-tocopherol placebo plus memantine placebo.

      The primary outcome for the study will be progression of AD as measured by the Alzheimer's
      Disease Cooperative Study/Activities of Daily Living (ADCS/ADL) inventory. The ADCS/ADL
      inventory is an established outcome measure that was designed to assess functional capacity
      over a broad range of dementia severity and to be sensitive in measuring dementia
      progression. Secondary outcome measures will include the following five instruments:
      Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-cog) (cognition), MMSE
      (cognition), The Dependence Scale (function), Neuropsychiatric Inventory (NPI) (behavior),
      and Caregiver Activity Survey (CAS) (caregiver time). Outcomes and safety assessments will be
      obtained at baseline and every six months. The target sample size for the trial will be 620
      patients (210 per treatment arm). This sample size will provide 90% power to detect a 4-point
      mean treatment difference in the ADCS/ADL inventory by the end of the average follow-up
      period, adjusted for losses. The effects to be detected are modest and translate into a 17.7%
      reduction in the annual rate of decline with each therapy given alone, and if the effects are
      additive, an approximate 35% reduction for combined therapy. These effects are equivalent to
      slowing the rate of progression of the disease by nearly 6 months for monotherapy and 12
      months for combined therapy. To achieve the target sample size, Veterans will be recruited
      over a 3-year period with an estimated minimum follow-up of 1 year and a maximum of 4 years.
      A total of 10 to 15 VA sites will be established to enroll an average of one Veteran every 2
      weeks. CSP#546 is designed to assess both a clinically and economically important treatment
      effect. If the study definitely determined that alpha-tocopherol, memantine, or the
      combination delays the progression of AD, the study would be tremendously valuable in
      reducing the financial and emotional costs of the disease in the VA and U.S. as a whole.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Alzheimer's Disease Cooperative Study/Activities of Daily Living (ADCS/ADL) Inventory Change From Baseline</measure>
    <time_frame>6, 12, 18, 24, 30, 36, 42 and 48 months minus baseline</time_frame>
    <description>The primary outcome of the study was the Alzheimer's Disease Cooperative Study/Activities of Daily Living (ADCS/ADL) Inventory. The ADCS/ADL Inventory is designed to assess functional abilities to perform activities of daily living in Alzheimer patients with a broad range of dementia severity. The total score ranges from 0 to 78 with higher scores indicating greater abilities. Outcome analysis is average least square means change from baseline.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mini-Mental State Examination Change From Baseline</measure>
    <time_frame>6, 12, 18, 24, 30, 36, 42 and 48 months minus baseline</time_frame>
    <description>The Mini-Mental State Examination (MMSE) briefly and objectively assess cognitive status in psychiatric patients with cognitive impairment. The MMSE questions are grouped into seven categories, each representing a different cognitive domain. The MMSE yields a total score that ranges from 0 for a patient who gives no correct response to a score of 30 for a patient who makes no errors. Outcome analysis is average least square means change from baseline.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Alzheimer's Disease Assessment Scale - Cognitive (ADAS-cog) Change From Baseline</measure>
    <time_frame>6, 12, 18, 24, 30, 36, 42 and 48 months minus baseline</time_frame>
    <description>The Alzheimer's Disease Assessment Scale (ADAS) is a 21-item scale designed to assess the severity of cognitive and non-cognitive behavioral impairments in patients with Alzheimer's disease. The cognitive portion of the scale (ADAS-cog) consists of 11 items to assess memory, language, and praxis functions. The ADAS-cog total score ranges from 0 (no errors) to 70 (severe cognitive impairment). Outcome analysis is average least square means change from baseline.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neuropsychiatric Inventory Change From Baseline</measure>
    <time_frame>6, 12, 18, 24, 30, 36, 42 and 48 months minus baseline</time_frame>
    <description>The Neuropsychiatric Inventory (NPI) assesses psychological and behavioral problems in patients with dementia. For each of twelve domains, there are four scores: frequency, severity, total frequency x severity, and caregiver distress. The frequency x severity total scores from each domain are summed for an overall total score that ranges from 0 to 144. The total caregiver distress scores are also summed for an overall total caregiver distress score that ranges from 0 to 60. The secondary endpoint for the trial will be the overall frequency times severity total score. Outcome analysis is average least square means change from baseline.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Caregiver Activity Survey Change From Baseline</measure>
    <time_frame>6, 12, 18, 24, 30, 36, 42 and 48 months minus baseline</time_frame>
    <description>The Caregiver Activity Survey (CAS) was developed to measure the time caregivers spend aiding Alzheimer patients with their day-to-day activities. The CAS consists of six items that ask for an estimate in hours and minutes of the time that the caregiver spent during the previous 24 hours performing these particular activities. The six CAS items are as follows: 1) communication with the person, 2) using transportation, 3) dressing, 4) eating, 5) looking after one's appearance, and 6) supervising the person. The more caregiving hours the worse the patient's functioning level. Outcome analysis is average least square means change from baseline.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dependence Scale: Time to Event Analysis (Increase of of One Dependence Level)</measure>
    <time_frame>Every 6 months to a maximum of 4 years</time_frame>
    <description>The Dependence Scale assesses the level of assistance needed by patients with Alzheimer's disease for activities of daily living. The scale yields six levels of dependence: no assistance required (Level 0); requires occasional reminders (Level 1); requires frequent reminders and/or help with household chores (Level 2); needs daily supervision (Level 3); needs to be dressed, toileted or fed (Level 4); needs to be transferred, diapered or tube fed (Level 5).</description>
  </secondary_outcome>
  <other_outcome>
    <measure>All-cause Mortality</measure>
    <time_frame>up to 4 years</time_frame>
    <description>Survival analysis of death from any cause.</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">613</enrollment>
  <condition>Alzheimer's Disease</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2,000 IU per day of dl-alpha-tocopherol plus placebo for memantine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 mg per day of memantine plus placebo for dl-alpha-tocopherol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Combination of 2,000 IU per day of dl-alpha-tocopherol and 20 mg per day of memantine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 4</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Matching placebos for dl-alpha-tocopherol and memantine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dl-alpha-tocopherol</intervention_name>
    <description>Alpha-tocopherol will be given as an oral dose of 1000 IU twice a day (morning and evening). The form of vitamin E that will be used in this study will be hard gel capsules of dl-alpha-tocopheryl acetate (&quot;synthetic&quot;) vitamin E.</description>
    <arm_group_label>Arm 1</arm_group_label>
    <other_name>Vitamin E</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Memantine</intervention_name>
    <description>A moderate-affinity NMDA antagonist. Memantine will be titrated over four weeks to a maintenance dose of 10 mg twice a day. During week 1 patients will take one 5-mg memantine tablet in the morning. During week 2 patients will take one 5-mg memantine tablet in the morning and one in the evening. During week 3 patients will take two 5-mg memantine tablets in the morning and one 5-mg tablet in the evening. Beginning with week 4, participants will take four 5-mg tablets daily, two in the morning and two in the evening.</description>
    <arm_group_label>Arm 2</arm_group_label>
    <other_name>Namenda (R)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dl-alpha-tocopherol</intervention_name>
    <description>Alpha-tocopherol will be given as an oral dose of 1000 IU twice a day (morning and evening). The form of vitamin E that will be used in this study will be hard gel capsules of dl-alpha-tocopheryl acetate (&quot;synthetic&quot;) vitamin E.</description>
    <arm_group_label>Arm 3</arm_group_label>
    <other_name>Vitamin E</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Memantine</intervention_name>
    <description>A moderate-affinity NMDA antagonist. Memantine will be titrated over four weeks to a maintenance dose of 10 mg twice a day. During week 1 patients will take one 5-mg memantine tablet in the morning. During week 2 patients will take one 5-mg memantine tablet in the morning and one in the evening. During week 3 patients will take two 5-mg memantine tablets in the morning and one 5-mg tablet in the evening. Beginning with week 4, participants will take four 5-mg tablets daily, two in the morning and two in the evening.</description>
    <arm_group_label>Arm 3</arm_group_label>
    <other_name>Namenda (R)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Matching placebos for dl-alpha-tocopherol and memantine.</description>
    <arm_group_label>Arm 4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Diagnoses of possible or probable Alzheimer's disease (NINCDS-ADRDA)

          2. Presence of a caregiver (friend or relative) who can assume responsibility for
             medication compliance, can accompany the patient to all visits, and rate patient's
             condition

          3. Written informed consent from both the patient (or surrogate) and caregiver

          4. An MMSE score between 12 and 26 inclusive

          5. Administration of a maintenance dosage of donepezil (5-10mg/d), rivastigmine
             (6-12mg/d) or rivastigmine (Exelon) patch (4.6 mg or 9.5 mg), galantamine or
             galantamine ER (16-24mg/d) for a minimum of 4 weeks prior to randomization

          6. Agreement not to take vitamin E supplements and/or memantine outside of the study
             (daily multivitamin is permitted containing up to 100 IU alpha-tocopherol)

        Exclusion Criteria:

          1. A non-Alzheimer primary dementia (e.g., vascular dementia, Lewy body dementia,
             fronto-temporal dementia, vitamin B-12 deficiency, hypothyroidism)

          2. Current major depression, delirium, alcohol or psychoactive substance abuse or
             dependency, schizophrenia, or delusional disorder as defined by DSM-IV

          3. Presence of any uncontrolled systemic illness that would interfere with participation
             in the study or a life expectancy of less than one year

          4. Pregnant or intention to become pregnant

          5. Enrollment in another interventional clinical trial

          6. Current prescription with more than one AChE inhibitor

          7. Current prescription for warfarin

          8. Use of vitamin E supplements in the past 2 weeks

          9. Use of memantine in the past 4 weeks or known intolerance

         10. Estimated creatinine clearance less than 5ml/min (Cockcroft-Gault formula)

         11. Use of amantadine in the past 2 weeks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maurice Dysken</last_name>
    <role>Study Chair</role>
    <affiliation>Minneapolis Veterans Affairs Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Medical Center, Bay Pines</name>
      <address>
        <city>Bay Pines</city>
        <state>Florida</state>
        <zip>33708</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33125</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Iowa City</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52246-2208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Maryland Health Care System, Baltimore</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Jamaica Plain Campus</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Ann Arbor Healthcare System</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48113</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Minneapolis</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55417</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Salisbury VAMC</name>
      <address>
        <city>Salisbury</city>
        <state>North Carolina</state>
        <zip>28144</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, Cleveland</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ralph H Johnson VA Medical Center, Charleston</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29401-5799</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA North Texas Health Care System, Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Puget Sound Health Care System, Seattle</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wlliam S. Middleton Memorial Veterans Hospital, Madison</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Medical Center, San Juan</name>
      <address>
        <city>San Juan</city>
        <zip>00921</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Puerto Rico</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Dysken MW, Guarino PD, Vertrees JE, Asthana S, Sano M, Llorente M, Pallaki M, Love S, Schellenberg GD, McCarten JR, Malphurs J, Prieto S, Chen P, Loreck DJ, Carney S, Trapp G, Bakshi RS, Mintzer JE, Heidebrink JL, Vidal-Cardona A, Arroyo LM, Cruz AR, Kowall NW, Chopra MP, Craft S, Thielke S, Turvey CL, Woodman C, Monnell KA, Gordon K, Tomaska J, Vatassery G. Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data. Alzheimers Dement. 2014 Jan;10(1):36-44. doi: 10.1016/j.jalz.2013.01.014. Epub 2013 Apr 11.</citation>
    <PMID>23583234</PMID>
  </reference>
  <results_reference>
    <citation>Dysken MW, Sano M, Asthana S, Vertrees JE, Pallaki M, Llorente M, Love S, Schellenberg GD, McCarten JR, Malphurs J, Prieto S, Chen P, Loreck DJ, Trapp G, Bakshi RS, Mintzer JE, Heidebrink JL, Vidal-Cardona A, Arroyo LM, Cruz AR, Zachariah S, Kowall NW, Chopra MP, Craft S, Thielke S, Turvey CL, Woodman C, Monnell KA, Gordon K, Tomaska J, Segal Y, Peduzzi PN, Guarino PD. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA. 2014 Jan 1;311(1):33-44. doi: 10.1001/jama.2013.282834. Erratum in: JAMA. 2014 Mar 19;311(11):1161.</citation>
    <PMID>24381967</PMID>
  </results_reference>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2005</study_first_submitted>
  <study_first_submitted_qc>October 6, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2005</study_first_posted>
  <results_first_submitted>December 6, 2013</results_first_submitted>
  <results_first_submitted_qc>January 23, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 29, 2014</results_first_posted>
  <last_update_submitted>July 14, 2014</last_update_submitted>
  <last_update_submitted_qc>July 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 23, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Alzheimer's Disease</keyword>
  <keyword>clinical trial</keyword>
  <keyword>randomized controlled trial</keyword>
  <keyword>alpha-tocopherol</keyword>
  <keyword>vitamin E</keyword>
  <keyword>Namenda</keyword>
  <keyword>memantine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Tocopherols</mesh_term>
    <mesh_term>Tocotrienols</mesh_term>
    <mesh_term>alpha-Tocopherol</mesh_term>
    <mesh_term>Memantine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment initiated in August, 2007 and concluded in March, 2012. Enrollment took place at 14 VA medical centers.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Vitamin E</title>
          <description>Alpha-tocopherol (vitamin E in the form of dl-alpha-tocopheryl acetate), 2000 international units (IU) per day, taken as one 1000 IU hard-gelatin, liquid-filled capsules twice a day plus matching memantine placebos.</description>
        </group>
        <group group_id="P2">
          <title>Memantine (Namenda)</title>
          <description>Memantine 20 mg per day, titrated over four weeks to a maintenance dosage of 10 mg pills taken twice a day plus matching vitamin E placebo.</description>
        </group>
        <group group_id="P3">
          <title>Vitamin E + Memantine</title>
          <description>2000 IU of Alpha-tocopherol (vitamin E) per day plus 20 mg memantine per day.</description>
        </group>
        <group group_id="P4">
          <title>Placebo</title>
          <description>Matching placebo pills for vitamin E and memantine</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="152"/>
                <participants group_id="P2" count="155"/>
                <participants group_id="P3" count="154"/>
                <participants group_id="P4" count="152"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="90"/>
                <participants group_id="P2" count="88"/>
                <participants group_id="P3" count="89"/>
                <participants group_id="P4" count="90"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="62"/>
                <participants group_id="P2" count="67"/>
                <participants group_id="P3" count="65"/>
                <participants group_id="P4" count="62"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="39"/>
                <participants group_id="P3" count="32"/>
                <participants group_id="P4" count="31"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="19"/>
                <participants group_id="P3" count="17"/>
                <participants group_id="P4" count="18"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="14"/>
                <participants group_id="P4" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Vitamin E</title>
          <description>Alpha-tocopherol (vitamin E in the form of dl-alpha-tocopheryl acetate), 2000 international units (IU) per day, taken as one 1000 IU hard-gelatin, liquid-filled capsules twice a day plus matching memantine placebos.</description>
        </group>
        <group group_id="B2">
          <title>Memantine (Namenda)</title>
          <description>Memantine 20 mg per day, titrated over four weeks to a maintenance dosage of 10 mg pills taken twice a day plus matching vitamin E placebo.</description>
        </group>
        <group group_id="B3">
          <title>Vitamin E + Memantine</title>
          <description>2000 IU of Alpha-tocopherol (vitamin E) per day plus 20 mg memantine per day.</description>
        </group>
        <group group_id="B4">
          <title>Placebo</title>
          <description>Matching placebo pills for vitamin E and memantine</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="152"/>
            <count group_id="B2" value="155"/>
            <count group_id="B3" value="154"/>
            <count group_id="B4" value="152"/>
            <count group_id="B5" value="613"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="78.6" spread="7.2"/>
                    <measurement group_id="B2" value="78.8" spread="7.2"/>
                    <measurement group_id="B3" value="78.3" spread="7.0"/>
                    <measurement group_id="B4" value="79.4" spread="7.0"/>
                    <measurement group_id="B5" value="78.8" spread="7.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="146"/>
                    <measurement group_id="B2" value="149"/>
                    <measurement group_id="B3" value="150"/>
                    <measurement group_id="B4" value="149"/>
                    <measurement group_id="B5" value="594"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="19"/>
                    <measurement group_id="B5" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="135"/>
                    <measurement group_id="B2" value="140"/>
                    <measurement group_id="B3" value="139"/>
                    <measurement group_id="B4" value="133"/>
                    <measurement group_id="B5" value="547"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="18"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="130"/>
                    <measurement group_id="B2" value="132"/>
                    <measurement group_id="B3" value="136"/>
                    <measurement group_id="B4" value="131"/>
                    <measurement group_id="B5" value="529"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="152"/>
                    <measurement group_id="B2" value="155"/>
                    <measurement group_id="B3" value="154"/>
                    <measurement group_id="B4" value="152"/>
                    <measurement group_id="B5" value="613"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Education</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;High School Graduation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="26"/>
                    <measurement group_id="B4" value="29"/>
                    <measurement group_id="B5" value="137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>High School Graduation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="48"/>
                    <measurement group_id="B3" value="57"/>
                    <measurement group_id="B4" value="56"/>
                    <measurement group_id="B5" value="207"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Some College</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="37"/>
                    <measurement group_id="B4" value="33"/>
                    <measurement group_id="B5" value="135"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>College Graduation or Advanced Degree</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="34"/>
                    <measurement group_id="B4" value="34"/>
                    <measurement group_id="B5" value="134"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Apolipoprotein E ε4 status</title>
          <description>Data collected through genetic sub-study with separate informed consent.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Non-carriers</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                    <measurement group_id="B2" value="48"/>
                    <measurement group_id="B3" value="59"/>
                    <measurement group_id="B4" value="55"/>
                    <measurement group_id="B5" value="209"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>One ε4 allele</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="44"/>
                    <measurement group_id="B4" value="38"/>
                    <measurement group_id="B5" value="165"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Two ε4 alleles</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Tested</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="43"/>
                    <measurement group_id="B4" value="49"/>
                    <measurement group_id="B5" value="198"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Concomitant Medications Acetylcholinesterase Inhibitors (AChEI)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Donepezil</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="104"/>
                    <measurement group_id="B2" value="100"/>
                    <measurement group_id="B3" value="100"/>
                    <measurement group_id="B4" value="96"/>
                    <measurement group_id="B5" value="400"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Galantamine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="49"/>
                    <measurement group_id="B4" value="55"/>
                    <measurement group_id="B5" value="194"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Rivastigmine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weeks from AChEI Initiation to Randomization</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>≤ 12 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="49"/>
                    <measurement group_id="B4" value="37"/>
                    <measurement group_id="B5" value="168"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt; 12 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="105"/>
                    <measurement group_id="B2" value="119"/>
                    <measurement group_id="B3" value="104"/>
                    <measurement group_id="B4" value="115"/>
                    <measurement group_id="B5" value="443"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Alzheimer's Disease Cooperative Study/Activities of Daily Living Inventory</title>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56.6" spread="14.9"/>
                    <measurement group_id="B2" value="57.3" spread="14.2"/>
                    <measurement group_id="B3" value="56.4" spread="14.0"/>
                    <measurement group_id="B4" value="56.8" spread="13.7"/>
                    <measurement group_id="B5" value="56.8" spread="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mini-Mental State Examination</title>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21.3" spread="3.3"/>
                    <measurement group_id="B2" value="20.8" spread="3.8"/>
                    <measurement group_id="B3" value="21.3" spread="3.4"/>
                    <measurement group_id="B4" value="20.8" spread="3.8"/>
                    <measurement group_id="B5" value="21.0" spread="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Alzheimer's Disease Assessment Scale - Cognitive portion</title>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18.5" spread="8.8"/>
                    <measurement group_id="B2" value="19.5" spread="7.9"/>
                    <measurement group_id="B3" value="18.0" spread="8.4"/>
                    <measurement group_id="B4" value="19.1" spread="8.4"/>
                    <measurement group_id="B5" value="18.8" spread="8.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Neuropsychiatric Inventory</title>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12.2" spread="13.3"/>
                    <measurement group_id="B2" value="12.1" spread="13.1"/>
                    <measurement group_id="B3" value="12.3" spread="13.3"/>
                    <measurement group_id="B4" value="13.5" spread="14.2"/>
                    <measurement group_id="B5" value="12.5" spread="13.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Caregiver Activity Survey</title>
          <units>hours per day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.3" spread="14.3"/>
                    <measurement group_id="B2" value="6.7" spread="9.0"/>
                    <measurement group_id="B3" value="6.6" spread="10.5"/>
                    <measurement group_id="B4" value="6.5" spread="9.2"/>
                    <measurement group_id="B5" value="6.8" spread="10.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Dependence Scale</title>
          <description>Higher the level the more dependence / less independence.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Level 0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Level 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Level 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="85"/>
                    <measurement group_id="B2" value="91"/>
                    <measurement group_id="B3" value="80"/>
                    <measurement group_id="B4" value="79"/>
                    <measurement group_id="B5" value="335"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Level 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="31"/>
                    <measurement group_id="B4" value="37"/>
                    <measurement group_id="B5" value="134"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Level 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Level 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Alzheimer's Disease Cooperative Study/Activities of Daily Living (ADCS/ADL) Inventory Change From Baseline</title>
        <description>The primary outcome of the study was the Alzheimer's Disease Cooperative Study/Activities of Daily Living (ADCS/ADL) Inventory. The ADCS/ADL Inventory is designed to assess functional abilities to perform activities of daily living in Alzheimer patients with a broad range of dementia severity. The total score ranges from 0 to 78 with higher scores indicating greater abilities. Outcome analysis is average least square means change from baseline.</description>
        <time_frame>6, 12, 18, 24, 30, 36, 42 and 48 months minus baseline</time_frame>
        <population>Intention-to-treat analysis that includes all participants with baseline and at least one follow-up measurement.</population>
        <group_list>
          <group group_id="O1">
            <title>Vitamin E</title>
            <description>Alpha-tocopherol (vitamin E in the form of dl-alpha-tocopheryl acetate), 2000 international units (IU) per day, taken as one 1000 IU hard-gelatin, liquid-filled capsules twice a day plus matching memantine placebos.</description>
          </group>
          <group group_id="O2">
            <title>Memantine</title>
            <description>Memantine 20 mg per day, titrated over four weeks to a maintenance dosage of 10 mg pills taken twice a day plus matching vitamin E placebo.</description>
          </group>
          <group group_id="O3">
            <title>Vitamin E + Memantine</title>
            <description>2000 IU of Alpha-tocopherol (vitamin E) per day plus 20 mg memantine per day.</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Matching placebo pills for vitamin E and memantine</description>
          </group>
        </group_list>
        <measure>
          <title>Alzheimer's Disease Cooperative Study/Activities of Daily Living (ADCS/ADL) Inventory Change From Baseline</title>
          <description>The primary outcome of the study was the Alzheimer's Disease Cooperative Study/Activities of Daily Living (ADCS/ADL) Inventory. The ADCS/ADL Inventory is designed to assess functional abilities to perform activities of daily living in Alzheimer patients with a broad range of dementia severity. The total score ranges from 0 to 78 with higher scores indicating greater abilities. Outcome analysis is average least square means change from baseline.</description>
          <population>Intention-to-treat analysis that includes all participants with baseline and at least one follow-up measurement.</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="142"/>
                <count group_id="O3" value="139"/>
                <count group_id="O4" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>6 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.72" spread="0.95"/>
                    <measurement group_id="O2" value="-2.40" spread="0.94"/>
                    <measurement group_id="O3" value="-2.78" spread="0.96"/>
                    <measurement group_id="O4" value="-4.52" spread="0.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.29" spread="1.20"/>
                    <measurement group_id="O2" value="-6.99" spread="1.21"/>
                    <measurement group_id="O3" value="-6.60" spread="1.21"/>
                    <measurement group_id="O4" value="-8.11" spread="1.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8.01" spread="1.40"/>
                    <measurement group_id="O2" value="-9.32" spread="1.42"/>
                    <measurement group_id="O3" value="-7.98" spread="1.41"/>
                    <measurement group_id="O4" value="-10.21" spread="1.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11.88" spread="1.66"/>
                    <measurement group_id="O2" value="-14.06" spread="1.70"/>
                    <measurement group_id="O3" value="-12.82" spread="1.68"/>
                    <measurement group_id="O4" value="-16.18" spread="1.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-15.84" spread="1.94"/>
                    <measurement group_id="O2" value="-18.30" spread="1.97"/>
                    <measurement group_id="O3" value="-15.66" spread="1.97"/>
                    <measurement group_id="O4" value="-19.67" spread="2.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>36 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-19.71" spread="2.34"/>
                    <measurement group_id="O2" value="-18.78" spread="2.43"/>
                    <measurement group_id="O3" value="-18.89" spread="2.32"/>
                    <measurement group_id="O4" value="-24.82" spread="2.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>42 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-25.30" spread="2.57"/>
                    <measurement group_id="O2" value="-23.48" spread="2.65"/>
                    <measurement group_id="O3" value="-23.44" spread="2.52"/>
                    <measurement group_id="O4" value="-28.13" spread="2.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-26.55" spread="3.11"/>
                    <measurement group_id="O2" value="-24.60" spread="3.18"/>
                    <measurement group_id="O3" value="-29.25" spread="3.08"/>
                    <measurement group_id="O4" value="-27.55" spread="3.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-13.81" spread="1.11"/>
                    <measurement group_id="O2" value="-14.98" spread="1.10"/>
                    <measurement group_id="O3" value="-15.20" spread="1.11"/>
                    <measurement group_id="O4" value="-16.96" spread="1.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.03</p_value>
            <p_value_desc>p-value adjusted for 6 treatment group comparisons.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>3.15</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.92</ci_lower_limit>
            <ci_upper_limit>5.39</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E group minus the placebo group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.40</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>1.98</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.24</ci_lower_limit>
            <ci_upper_limit>4.20</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the memantine group minus the placebo group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.49</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>1.76</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.48</ci_lower_limit>
            <ci_upper_limit>4.00</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E + memantine group minus the placebo group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.60</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-1.39</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.63</ci_lower_limit>
            <ci_upper_limit>0.85</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E + memantine group minus the vitamin E group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.85</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.22</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.44</ci_lower_limit>
            <ci_upper_limit>2.01</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E + memantine group minus the memantine group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.60</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>1.18</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.04</ci_lower_limit>
            <ci_upper_limit>3.39</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E group minus the memantine group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Dependence Scale: Time to Event Analysis (Increase of of One Dependence Level)</title>
        <description>The Dependence Scale assesses the level of assistance needed by patients with Alzheimer's disease for activities of daily living. The scale yields six levels of dependence: no assistance required (Level 0); requires occasional reminders (Level 1); requires frequent reminders and/or help with household chores (Level 2); needs daily supervision (Level 3); needs to be dressed, toileted or fed (Level 4); needs to be transferred, diapered or tube fed (Level 5).</description>
        <time_frame>Every 6 months to a maximum of 4 years</time_frame>
        <population>Intention-to-treat analysis that includes all participants with baseline and at least one follow-up measurement.</population>
        <group_list>
          <group group_id="O1">
            <title>Vitamin E</title>
            <description>Alpha-tocopherol (vitamin E in the form of dl-alpha-tocopheryl acetate), 2000 international units (IU) per day, taken as one 1000 IU hard-gelatin, liquid-filled capsules twice a day plus matching memantine placebos.</description>
          </group>
          <group group_id="O2">
            <title>Memantine</title>
            <description>Memantine 20 mg per day, titrated over four weeks to a maintenance dosage of 10 mg pills taken twice a day plus matching vitamin E placebo.</description>
          </group>
          <group group_id="O3">
            <title>Vitamin E + Memantine</title>
            <description>2000 IU of Alpha-tocopherol (vitamin E) per day plus 20 mg memantine per day.</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Matching placebo pills for vitamin E and memantine</description>
          </group>
        </group_list>
        <measure>
          <title>Dependence Scale: Time to Event Analysis (Increase of of One Dependence Level)</title>
          <description>The Dependence Scale assesses the level of assistance needed by patients with Alzheimer's disease for activities of daily living. The scale yields six levels of dependence: no assistance required (Level 0); requires occasional reminders (Level 1); requires frequent reminders and/or help with household chores (Level 2); needs daily supervision (Level 3); needs to be dressed, toileted or fed (Level 4); needs to be transferred, diapered or tube fed (Level 5).</description>
          <population>Intention-to-treat analysis that includes all participants with baseline and at least one follow-up measurement.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="142"/>
                <count group_id="O3" value="139"/>
                <count group_id="O4" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80"/>
                    <measurement group_id="O2" value="87"/>
                    <measurement group_id="O3" value="87"/>
                    <measurement group_id="O4" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.69</p_value>
            <p_value_desc>p- value is unadjusted for multiple comparisons because its a 3 degrees of freedom test for any treatment group differences</p_value_desc>
            <method>Log Rank</method>
            <method_desc>3 degrees of freedom test</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mini-Mental State Examination Change From Baseline</title>
        <description>The Mini-Mental State Examination (MMSE) briefly and objectively assess cognitive status in psychiatric patients with cognitive impairment. The MMSE questions are grouped into seven categories, each representing a different cognitive domain. The MMSE yields a total score that ranges from 0 for a patient who gives no correct response to a score of 30 for a patient who makes no errors. Outcome analysis is average least square means change from baseline.</description>
        <time_frame>6, 12, 18, 24, 30, 36, 42 and 48 months minus baseline</time_frame>
        <population>Intention-to-treat analysis that includes all participants with baseline and at least one follow-up measurement.</population>
        <group_list>
          <group group_id="O1">
            <title>Vitamin E</title>
            <description>Alpha-tocopherol (vitamin E in the form of dl-alpha-tocopheryl acetate), 2000 international units (IU) per day, taken as one 1000 IU hard-gelatin, liquid-filled capsules twice a day plus matching memantine placebos.</description>
          </group>
          <group group_id="O2">
            <title>Memantine</title>
            <description>Memantine 20 mg per day, titrated over four weeks to a maintenance dosage of 10 mg pills taken twice a day plus matching vitamin E placebo.</description>
          </group>
          <group group_id="O3">
            <title>Vitamin E + Memantine</title>
            <description>2000 IU of Alpha-tocopherol (vitamin E) per day plus 20 mg memantine per day.</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Matching placebo pills for vitamin E and memantine</description>
          </group>
        </group_list>
        <measure>
          <title>Mini-Mental State Examination Change From Baseline</title>
          <description>The Mini-Mental State Examination (MMSE) briefly and objectively assess cognitive status in psychiatric patients with cognitive impairment. The MMSE questions are grouped into seven categories, each representing a different cognitive domain. The MMSE yields a total score that ranges from 0 for a patient who gives no correct response to a score of 30 for a patient who makes no errors. Outcome analysis is average least square means change from baseline.</description>
          <population>Intention-to-treat analysis that includes all participants with baseline and at least one follow-up measurement.</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="136"/>
                <count group_id="O2" value="140"/>
                <count group_id="O3" value="136"/>
                <count group_id="O4" value="137"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>6 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.35" spread="0.29"/>
                    <measurement group_id="O2" value="-0.24" spread="0.28"/>
                    <measurement group_id="O3" value="-0.20" spread="0.29"/>
                    <measurement group_id="O4" value="-0.34" spread="0.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.95" spread="0.34"/>
                    <measurement group_id="O2" value="-1.09" spread="0.34"/>
                    <measurement group_id="O3" value="-0.65" spread="0.34"/>
                    <measurement group_id="O4" value="-1.39" spread="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.00" spread="0.44"/>
                    <measurement group_id="O2" value="-2.62" spread="0.45"/>
                    <measurement group_id="O3" value="-1.22" spread="0.44"/>
                    <measurement group_id="O4" value="-2.21" spread="0.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.62" spread="0.52"/>
                    <measurement group_id="O2" value="-3.44" spread="0.54"/>
                    <measurement group_id="O3" value="-2.29" spread="0.53"/>
                    <measurement group_id="O4" value="-2.90" spread="0.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.67" spread="0.61"/>
                    <measurement group_id="O2" value="-3.79" spread="0.63"/>
                    <measurement group_id="O3" value="-3.16" spread="0.61"/>
                    <measurement group_id="O4" value="-3.26" spread="0.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>36 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.97" spread="0.74"/>
                    <measurement group_id="O2" value="-4.26" spread="0.78"/>
                    <measurement group_id="O3" value="-3.69" spread="0.73"/>
                    <measurement group_id="O4" value="-3.87" spread="0.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>42 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.84" spread="0.79"/>
                    <measurement group_id="O2" value="-4.59" spread="0.80"/>
                    <measurement group_id="O3" value="-3.80" spread="0.74"/>
                    <measurement group_id="O4" value="-4.68" spread="0.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.26" spread="0.94"/>
                    <measurement group_id="O2" value="-5.98" spread="0.98"/>
                    <measurement group_id="O3" value="-5.70" spread="0.91"/>
                    <measurement group_id="O4" value="-5.42" spread="1.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.97" spread="0.33"/>
                    <measurement group_id="O2" value="-3.05" spread="0.33"/>
                    <measurement group_id="O3" value="-2.80" spread="0.33"/>
                    <measurement group_id="O4" value="-3.16" spread="0.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.84</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.19</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.54</ci_lower_limit>
            <ci_upper_limit>0.92</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E group minus the placebo group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.84</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.12</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.61</ci_lower_limit>
            <ci_upper_limit>0.84</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the memantine group minus the placebo group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.84</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.37</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.36</ci_lower_limit>
            <ci_upper_limit>1.10</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E + memantine group minus the placebo group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.84</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.17</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-0.56</ci_lower_limit>
            <ci_upper_limit>0.90</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E + memantine group minus the vitamin E group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.84</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.25</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.47</ci_lower_limit>
            <ci_upper_limit>0.98</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E + memantine group minus the memantine group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.84</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.08</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.65</ci_lower_limit>
            <ci_upper_limit>0.80</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E group minus the memantine group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Alzheimer's Disease Assessment Scale - Cognitive (ADAS-cog) Change From Baseline</title>
        <description>The Alzheimer's Disease Assessment Scale (ADAS) is a 21-item scale designed to assess the severity of cognitive and non-cognitive behavioral impairments in patients with Alzheimer's disease. The cognitive portion of the scale (ADAS-cog) consists of 11 items to assess memory, language, and praxis functions. The ADAS-cog total score ranges from 0 (no errors) to 70 (severe cognitive impairment). Outcome analysis is average least square means change from baseline.</description>
        <time_frame>6, 12, 18, 24, 30, 36, 42 and 48 months minus baseline</time_frame>
        <population>Intention-to-treat analysis that includes all participants with baseline and at least one follow-up measurement.</population>
        <group_list>
          <group group_id="O1">
            <title>Vitamin E</title>
            <description>Alpha-tocopherol (vitamin E in the form of dl-alpha-tocopheryl acetate), 2000 international units (IU) per day, taken as one 1000 IU hard-gelatin, liquid-filled capsules twice a day plus matching memantine placebos.</description>
          </group>
          <group group_id="O2">
            <title>Memantine</title>
            <description>Memantine 20 mg per day, titrated over four weeks to a maintenance dosage of 10 mg pills taken twice a day plus matching vitamin E placebo.</description>
          </group>
          <group group_id="O3">
            <title>Vitamin E + Memantine</title>
            <description>2000 IU of Alpha-tocopherol (vitamin E) per day plus 20 mg memantine per day.</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Matching placebo pills for vitamin E and memantine</description>
          </group>
        </group_list>
        <measure>
          <title>Alzheimer's Disease Assessment Scale - Cognitive (ADAS-cog) Change From Baseline</title>
          <description>The Alzheimer's Disease Assessment Scale (ADAS) is a 21-item scale designed to assess the severity of cognitive and non-cognitive behavioral impairments in patients with Alzheimer's disease. The cognitive portion of the scale (ADAS-cog) consists of 11 items to assess memory, language, and praxis functions. The ADAS-cog total score ranges from 0 (no errors) to 70 (severe cognitive impairment). Outcome analysis is average least square means change from baseline.</description>
          <population>Intention-to-treat analysis that includes all participants with baseline and at least one follow-up measurement.</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="135"/>
                <count group_id="O2" value="140"/>
                <count group_id="O3" value="136"/>
                <count group_id="O4" value="137"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>6 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.38" spread="0.63"/>
                    <measurement group_id="O2" value="1.11" spread="0.62"/>
                    <measurement group_id="O3" value="1.53" spread="0.63"/>
                    <measurement group_id="O4" value="3.04" spread="0.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.40" spread="0.72"/>
                    <measurement group_id="O2" value="3.32" spread="0.72"/>
                    <measurement group_id="O3" value="2.48" spread="0.72"/>
                    <measurement group_id="O4" value="4.26" spread="0.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.34" spread="0.91"/>
                    <measurement group_id="O2" value="5.69" spread="0.91"/>
                    <measurement group_id="O3" value="3.46" spread="0.90"/>
                    <measurement group_id="O4" value="6.04" spread="0.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.32" spread="1.10"/>
                    <measurement group_id="O2" value="6.73" spread="1.12"/>
                    <measurement group_id="O3" value="5.76" spread="1.11"/>
                    <measurement group_id="O4" value="6.71" spread="1.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.87" spread="1.31"/>
                    <measurement group_id="O2" value="7.64" spread="1.34"/>
                    <measurement group_id="O3" value="5.85" spread="1.30"/>
                    <measurement group_id="O4" value="8.90" spread="1.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>36 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.00" spread="1.53"/>
                    <measurement group_id="O2" value="8.31" spread="1.60"/>
                    <measurement group_id="O3" value="8.26" spread="1.50"/>
                    <measurement group_id="O4" value="10.77" spread="1.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>42 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.35" spread="1.60"/>
                    <measurement group_id="O2" value="8.24" spread="1.64"/>
                    <measurement group_id="O3" value="7.97" spread="1.51"/>
                    <measurement group_id="O4" value="10.61" spread="1.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.73" spread="1.87"/>
                    <measurement group_id="O2" value="11.74" spread="1.97"/>
                    <measurement group_id="O3" value="9.70" spread="1.82"/>
                    <measurement group_id="O4" value="10.85" spread="2.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.97" spread="0.70"/>
                    <measurement group_id="O2" value="6.38" spread="0.70"/>
                    <measurement group_id="O3" value="6.13" spread="0.71"/>
                    <measurement group_id="O4" value="7.78" spread="0.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.10</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-1.80</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.28</ci_lower_limit>
            <ci_upper_limit>-0.33</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E group minus the placebo group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.25</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-1.39</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.85</ci_lower_limit>
            <ci_upper_limit>0.07</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the memantine group minus the placebo group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.14</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-1.65</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.12</ci_lower_limit>
            <ci_upper_limit>-0.17</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E + memantine group minus the placebo group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.84</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.15</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.32</ci_lower_limit>
            <ci_upper_limit>1.63</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E + memantine group minus the vitamin E group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.84</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.26</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.72</ci_lower_limit>
            <ci_upper_limit>1.21</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E + memantine group minus the memantine group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.84</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.41</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.88</ci_lower_limit>
            <ci_upper_limit>1.06</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E group minus the memantine group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Neuropsychiatric Inventory Change From Baseline</title>
        <description>The Neuropsychiatric Inventory (NPI) assesses psychological and behavioral problems in patients with dementia. For each of twelve domains, there are four scores: frequency, severity, total frequency x severity, and caregiver distress. The frequency x severity total scores from each domain are summed for an overall total score that ranges from 0 to 144. The total caregiver distress scores are also summed for an overall total caregiver distress score that ranges from 0 to 60. The secondary endpoint for the trial will be the overall frequency times severity total score. Outcome analysis is average least square means change from baseline.</description>
        <time_frame>6, 12, 18, 24, 30, 36, 42 and 48 months minus baseline</time_frame>
        <population>Intention-to-treat analysis that includes all participants with baseline and at least one follow-up measurement.</population>
        <group_list>
          <group group_id="O1">
            <title>Vitamin E</title>
            <description>Alpha-tocopherol (vitamin E in the form of dl-alpha-tocopheryl acetate), 2000 international units (IU) per day, taken as one 1000 IU hard-gelatin, liquid-filled capsules twice a day plus matching memantine placebos.</description>
          </group>
          <group group_id="O2">
            <title>Memantine</title>
            <description>Memantine 20 mg per day, titrated over four weeks to a maintenance dosage of 10 mg pills taken twice a day plus matching vitamin E placebo.</description>
          </group>
          <group group_id="O3">
            <title>Vitamin E + Memantine</title>
            <description>2000 IU of Alpha-tocopherol (vitamin E) per day plus 20 mg memantine per day.</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Matching placebo pills for vitamin E and memantine</description>
          </group>
        </group_list>
        <measure>
          <title>Neuropsychiatric Inventory Change From Baseline</title>
          <description>The Neuropsychiatric Inventory (NPI) assesses psychological and behavioral problems in patients with dementia. For each of twelve domains, there are four scores: frequency, severity, total frequency x severity, and caregiver distress. The frequency x severity total scores from each domain are summed for an overall total score that ranges from 0 to 144. The total caregiver distress scores are also summed for an overall total caregiver distress score that ranges from 0 to 60. The secondary endpoint for the trial will be the overall frequency times severity total score. Outcome analysis is average least square means change from baseline.</description>
          <population>Intention-to-treat analysis that includes all participants with baseline and at least one follow-up measurement.</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="142"/>
                <count group_id="O3" value="139"/>
                <count group_id="O4" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>6 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.24" spread="1.07"/>
                    <measurement group_id="O2" value="-0.20" spread="1.06"/>
                    <measurement group_id="O3" value="-0.47" spread="1.08"/>
                    <measurement group_id="O4" value="0.46" spread="1.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.04" spread="1.21"/>
                    <measurement group_id="O2" value="0.31" spread="1.22"/>
                    <measurement group_id="O3" value="-0.17" spread="1.22"/>
                    <measurement group_id="O4" value="1.08" spread="1.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.93" spread="1.40"/>
                    <measurement group_id="O2" value="1.18" spread="1.43"/>
                    <measurement group_id="O3" value="0.41" spread="1.41"/>
                    <measurement group_id="O4" value="4.06" spread="1.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.16" spread="1.74"/>
                    <measurement group_id="O2" value="4.29" spread="1.79"/>
                    <measurement group_id="O3" value="1.98" spread="1.77"/>
                    <measurement group_id="O4" value="3.59" spread="1.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.21" spread="1.70"/>
                    <measurement group_id="O2" value="2.62" spread="1.71"/>
                    <measurement group_id="O3" value="2.16" spread="1.71"/>
                    <measurement group_id="O4" value="1.66" spread="1.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>36 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.15" spread="1.97"/>
                    <measurement group_id="O2" value="3.24" spread="2.07"/>
                    <measurement group_id="O3" value="2.79" spread="1.95"/>
                    <measurement group_id="O4" value="0.60" spread="2.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>42 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.81" spread="2.64"/>
                    <measurement group_id="O2" value="3.63" spread="2.75"/>
                    <measurement group_id="O3" value="1.85" spread="2.54"/>
                    <measurement group_id="O4" value="3.64" spread="2.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.60" spread="2.53"/>
                    <measurement group_id="O2" value="2.79" spread="2.60"/>
                    <measurement group_id="O3" value="5.14" spread="2.54"/>
                    <measurement group_id="O4" value="0.30" spread="2.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.79" spread="1.00"/>
                    <measurement group_id="O2" value="1.87" spread="1.00"/>
                    <measurement group_id="O3" value="1.79" spread="1.00"/>
                    <measurement group_id="O4" value="2.26" spread="1.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.94</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-1.46</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.55</ci_lower_limit>
            <ci_upper_limit>0.63</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E group minus the placebo group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.94</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.39</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.47</ci_lower_limit>
            <ci_upper_limit>1.70</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the memantine group minus the placebo group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.94</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.47</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.57</ci_lower_limit>
            <ci_upper_limit>1.63</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E + memantine group minus the placebo group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.94</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.99</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.09</ci_lower_limit>
            <ci_upper_limit>3.07</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E + memantine group minus the vitamin E group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.94</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.08</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.16</ci_lower_limit>
            <ci_upper_limit>1.99</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E + memantine group minus the memantine group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.94</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-1.08</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.14</ci_lower_limit>
            <ci_upper_limit>0.99</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E group minus the memantine group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Caregiver Activity Survey Change From Baseline</title>
        <description>The Caregiver Activity Survey (CAS) was developed to measure the time caregivers spend aiding Alzheimer patients with their day-to-day activities. The CAS consists of six items that ask for an estimate in hours and minutes of the time that the caregiver spent during the previous 24 hours performing these particular activities. The six CAS items are as follows: 1) communication with the person, 2) using transportation, 3) dressing, 4) eating, 5) looking after one's appearance, and 6) supervising the person. The more caregiving hours the worse the patient's functioning level. Outcome analysis is average least square means change from baseline.</description>
        <time_frame>6, 12, 18, 24, 30, 36, 42 and 48 months minus baseline</time_frame>
        <population>Intention-to-treat analysis that includes all participants with baseline and at least one follow-up measurement.</population>
        <group_list>
          <group group_id="O1">
            <title>Vitamin E</title>
            <description>Alpha-tocopherol (vitamin E in the form of dl-alpha-tocopheryl acetate), 2000 international units (IU) per day, taken as one 1000 IU hard-gelatin, liquid-filled capsules twice a day plus matching memantine placebos.</description>
          </group>
          <group group_id="O2">
            <title>Memantine</title>
            <description>Memantine 20 mg per day, titrated over four weeks to a maintenance dosage of 10 mg pills taken twice a day plus matching vitamin E placebo.</description>
          </group>
          <group group_id="O3">
            <title>Vitamin E + Memantine</title>
            <description>2000 IU of Alpha-tocopherol (vitamin E) per day plus 20 mg memantine per day.</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Matching placebo pills for vitamin E and memantine</description>
          </group>
        </group_list>
        <measure>
          <title>Caregiver Activity Survey Change From Baseline</title>
          <description>The Caregiver Activity Survey (CAS) was developed to measure the time caregivers spend aiding Alzheimer patients with their day-to-day activities. The CAS consists of six items that ask for an estimate in hours and minutes of the time that the caregiver spent during the previous 24 hours performing these particular activities. The six CAS items are as follows: 1) communication with the person, 2) using transportation, 3) dressing, 4) eating, 5) looking after one's appearance, and 6) supervising the person. The more caregiving hours the worse the patient's functioning level. Outcome analysis is average least square means change from baseline.</description>
          <population>Intention-to-treat analysis that includes all participants with baseline and at least one follow-up measurement.</population>
          <units>hours per day</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="142"/>
                <count group_id="O3" value="139"/>
                <count group_id="O4" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>6 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.93" spread="0.82"/>
                    <measurement group_id="O2" value="0.99" spread="0.81"/>
                    <measurement group_id="O3" value="1.08" spread="0.83"/>
                    <measurement group_id="O4" value="1.20" spread="0.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.18" spread="1.00"/>
                    <measurement group_id="O2" value="2.72" spread="1.01"/>
                    <measurement group_id="O3" value="1.39" spread="1.01"/>
                    <measurement group_id="O4" value="1.89" spread="1.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.12" spread="1.20"/>
                    <measurement group_id="O2" value="3.77" spread="1.22"/>
                    <measurement group_id="O3" value="2.69" spread="1.20"/>
                    <measurement group_id="O4" value="3.16" spread="1.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.60" spread="1.09"/>
                    <measurement group_id="O2" value="3.06" spread="1.13"/>
                    <measurement group_id="O3" value="2.82" spread="1.11"/>
                    <measurement group_id="O4" value="3.45" spread="1.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.14" spread="1.22"/>
                    <measurement group_id="O2" value="5.22" spread="1.25"/>
                    <measurement group_id="O3" value="3.41" spread="1.24"/>
                    <measurement group_id="O4" value="4.36" spread="1.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>36 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.69" spread="2.30"/>
                    <measurement group_id="O2" value="5.72" spread="2.43"/>
                    <measurement group_id="O3" value="4.90" spread="2.24"/>
                    <measurement group_id="O4" value="10.68" spread="2.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>42 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.95" spread="1.81"/>
                    <measurement group_id="O2" value="9.46" spread="1.89"/>
                    <measurement group_id="O3" value="5.48" spread="1.73"/>
                    <measurement group_id="O4" value="10.62" spread="1.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 months minus baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.17" spread="2.74"/>
                    <measurement group_id="O2" value="9.27" spread="2.80"/>
                    <measurement group_id="O3" value="13.80" spread="2.74"/>
                    <measurement group_id="O4" value="12.17" spread="3.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average change from baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.35" spread="0.78"/>
                    <measurement group_id="O2" value="5.52" spread="0.78"/>
                    <measurement group_id="O3" value="5.00" spread="0.78"/>
                    <measurement group_id="O4" value="5.14" spread="0.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.12</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-1.79</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.35</ci_lower_limit>
            <ci_upper_limit>-0.23</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E group minus the placebo group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.86</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.38</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.18</ci_lower_limit>
            <ci_upper_limit>1.94</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the memantine group minus the placebo group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.86</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.14</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.70</ci_lower_limit>
            <ci_upper_limit>1.42</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E + memantine group minus the placebo group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.14</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>1.65</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.11</ci_lower_limit>
            <ci_upper_limit>3.19</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E + memantine group minus the vitamin E group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.86</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.52</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.07</ci_lower_limit>
            <ci_upper_limit>1.02</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E + memantine group minus the memantine group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Longitudinal analysis to assess the average treatment effect over 48 months with visits at 6, 12, 18, 24, 30, 36, 42 and 48 months using all available data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.03</p_value>
            <p_value_desc>p-value is adjusted for 6 treatment group comparisons</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects model assuming data missing at random, adjusted for medical center as a random effect and for the baseline outcome score.</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-2.17</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.71</ci_lower_limit>
            <ci_upper_limit>-0.63</ci_upper_limit>
            <estimate_desc>Mean difference is the least squares mean changes from baseline for the vitamin E group minus the memantine group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>All-cause Mortality</title>
        <description>Survival analysis of death from any cause.</description>
        <time_frame>up to 4 years</time_frame>
        <population>Intention-to-treat analysis that includes all randomized participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Vitamin E</title>
            <description>Alpha-tocopherol (vitamin E in the form of dl-alpha-tocopheryl acetate), 2000 international units (IU) per day, taken as one 1000 IU hard-gelatin, liquid-filled capsules twice a day plus matching memantine placebos.</description>
          </group>
          <group group_id="O2">
            <title>Memantine</title>
            <description>Memantine 20 mg per day, titrated over four weeks to a maintenance dosage of 10 mg pills taken twice a day plus matching vitamin E placebo.</description>
          </group>
          <group group_id="O3">
            <title>Vitamin E + Memantine</title>
            <description>2000 IU of Alpha-tocopherol (vitamin E) per day plus 20 mg memantine per day.</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Matching placebo pills for vitamin E and memantine</description>
          </group>
        </group_list>
        <measure>
          <title>All-cause Mortality</title>
          <description>Survival analysis of death from any cause.</description>
          <population>Intention-to-treat analysis that includes all randomized participants.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="152"/>
                <count group_id="O2" value="155"/>
                <count group_id="O3" value="154"/>
                <count group_id="O4" value="152"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="39"/>
                    <measurement group_id="O3" value="32"/>
                    <measurement group_id="O4" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.31</p_value>
            <p_value_desc>p-value is unadjusted for multiple comparisons</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.87</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.67</ci_lower_limit>
            <ci_upper_limit>1.13</ci_upper_limit>
            <estimate_desc>Hazard ratio is for vitamin E group relative to the placebo group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.47</p_value>
            <p_value_desc>p-value is unadjusted for multiple comparisons</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.06</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.91</ci_lower_limit>
            <ci_upper_limit>1.24</ci_upper_limit>
            <estimate_desc>Hazard ratio is for the memantine group relative to the placebo group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.80</p_value>
            <p_value_desc>p-value is unadjusted for multiple comparisons</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.94</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.57</ci_lower_limit>
            <ci_upper_limit>1.54</ci_upper_limit>
            <estimate_desc>Hazard ratio is for the vitamin E + memantine group relative to the placebo group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Vitamin E</title>
          <description>Alpha-tocopherol (vitamin E in the form of dl-alpha-tocopheryl acetate), 2000 international units (IU) per day, taken as one 1000 IU hard-gelatin, liquid-filled capsules twice a day plus matching memantine placebos.</description>
        </group>
        <group group_id="E2">
          <title>Memantine</title>
          <description>Memantine 20 mg per day, titrated over four weeks to a maintenance dosage of 10 mg pills taken twice a day plus matching vitamin E placebo.</description>
        </group>
        <group group_id="E3">
          <title>Vitamin E + Memantine</title>
          <description>2000 IU of Alpha-tocopherol (vitamin E) per day plus 20 mg memantine per day.</description>
        </group>
        <group group_id="E4">
          <title>Placebo</title>
          <description>Matching placebo pills for vitamin E and memantine</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDra 15.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="82" subjects_at_risk="152"/>
                <counts group_id="E2" subjects_affected="84" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="83" subjects_at_risk="154"/>
                <counts group_id="E4" subjects_affected="95" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Microcytic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Blood and lymphatic system disorders</sub_title>
                <description>Sum of all adverse event terms in the Blood and Lymphatic Disorders System Organ Class</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="4" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis coronary artery</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E4" events="5" subjects_affected="3" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Atrioventricular block first degree</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cardiac failure acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cardiac failure chronic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="8" subjects_affected="4" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="5" subjects_affected="4" subjects_at_risk="154"/>
                <counts group_id="E4" events="7" subjects_affected="5" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cardiovascular disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cor pulmonale</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypertensive cardiomyopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Mitral valve incompetence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="152"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E4" events="5" subjects_affected="4" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Nodal arrhythmia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cardiac Disorders</sub_title>
                <description>Sum of all adverse event terms in the Cardiac Disorders System Organ Class</description>
                <counts group_id="E1" events="30" subjects_affected="19" subjects_at_risk="152"/>
                <counts group_id="E2" events="23" subjects_affected="16" subjects_at_risk="155"/>
                <counts group_id="E3" events="21" subjects_affected="19" subjects_at_risk="154"/>
                <counts group_id="E4" events="26" subjects_affected="20" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal haemorrhagic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastrointestinal disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastrointestinal obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastrointestinal ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Intestinal perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Large intestinal ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Oesophageal disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pancreatitis relapsing</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Peptic ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pharyngoesophageal diverticulum</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Small intestinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Disorders</sub_title>
                <description>Sum of all adverse event terms in the Gastrointestinal Disorders System Organ Class</description>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="152"/>
                <counts group_id="E2" events="18" subjects_affected="14" subjects_at_risk="155"/>
                <counts group_id="E3" events="13" subjects_affected="12" subjects_at_risk="154"/>
                <counts group_id="E4" events="10" subjects_affected="8" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adverse drug reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="5" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E4" events="4" subjects_affected="3" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Complication of device insertion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>General physical health deterioration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Implant site pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Medical device complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Stent-graft endoleak</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Sudden cardiac death</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>General Disorders</sub_title>
                <description>Sum of all adverse event terms in the General Disorders System Organ Class</description>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="152"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="155"/>
                <counts group_id="E3" events="10" subjects_affected="8" subjects_at_risk="154"/>
                <counts group_id="E4" events="15" subjects_affected="14" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gallbladder disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hepatobiliary Disorders</sub_title>
                <description>Sum of all adverse event terms in the Hepatobiliary Disorders System Organ Class</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Acarodermatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Bronchopneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Escherichia infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Escherichia urinary tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Fungal infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastritis viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastrointestinal infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Infected cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Latent tuberculosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Lobar pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Mycobacterium avium complex infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Nasal abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="11" subjects_affected="8" subjects_at_risk="152"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E3" events="15" subjects_affected="15" subjects_at_risk="154"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Sporotrichosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Tooth infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="152"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="155"/>
                <counts group_id="E3" events="13" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E4" events="5" subjects_affected="4" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Infections</sub_title>
                <description>Sum of all adverse event terms in the Infections and Infestations System Organ Class</description>
                <counts group_id="E1" events="29" subjects_affected="19" subjects_at_risk="152"/>
                <counts group_id="E2" events="31" subjects_affected="23" subjects_at_risk="155"/>
                <counts group_id="E3" events="44" subjects_affected="31" subjects_at_risk="154"/>
                <counts group_id="E4" events="13" subjects_affected="11" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accident at home</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Carbon monoxide poisoning</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Confusion postoperative</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Drug administration error</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="17" subjects_affected="15" subjects_at_risk="152"/>
                <counts group_id="E2" events="16" subjects_affected="14" subjects_at_risk="155"/>
                <counts group_id="E3" events="14" subjects_affected="12" subjects_at_risk="154"/>
                <counts group_id="E4" events="18" subjects_affected="15" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Haemodialysis-induced symptom</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Post procedural pulmonary embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Injury or Procedural Complications</sub_title>
                <description>Sum of all adverse event terms in the Injury, Poisoning and Procedural Complications System Organ Class</description>
                <counts group_id="E1" events="22" subjects_affected="18" subjects_at_risk="152"/>
                <counts group_id="E2" events="18" subjects_affected="15" subjects_at_risk="155"/>
                <counts group_id="E3" events="17" subjects_affected="15" subjects_at_risk="154"/>
                <counts group_id="E4" events="21" subjects_affected="18" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Bronchoscopy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Coagulation factor decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cystoscopy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Electrocardiogram change</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Heart rate increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Heart rate irregular</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Urine output decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Investigations</sub_title>
                <description>Sum of all adverse event terms in the Investigations System Organ Class</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="3" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Failure to thrive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hyperglycaemic hyperosmolar nonketotic syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypophagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Metabolism and Nutrition Disorders</sub_title>
                <description>Sum of all adverse event terms in the Matabolism and Nutrition Disorders System Organ Class</description>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="155"/>
                <counts group_id="E3" events="9" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E4" events="6" subjects_affected="6" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Acute myeloid leukaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Chronic lymphocytic leukaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Colon cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Colon cancer stage III</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Laryngeal cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Leukaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Lung cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Mesothelioma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Neoplasm malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's lymphoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Oesophageal cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Oesophageal carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Neoplasms</sub_title>
                <description>Sum of all adverse event terms in the Neoplasm System Organ Class</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="152"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="155"/>
                <counts group_id="E3" events="6" subjects_affected="4" subjects_at_risk="154"/>
                <counts group_id="E4" events="6" subjects_affected="6" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Altered state of consciousness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Aphasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Balance disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Brain mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Carotid artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cerebral amyloid angiopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cerebrovascular insufficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dementia Alzheimer's type</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Grand mal convulsion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Haemorrhagic stroke</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic unconsciousness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Mental impairment</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Motor dysfunction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E4" events="5" subjects_affected="4" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Unresponsive to stimuli</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Nervous System Disorders</sub_title>
                <description>Sum of all adverse event terms in the Nervous System Disorders System Organ Class</description>
                <counts group_id="E1" events="15" subjects_affected="12" subjects_at_risk="152"/>
                <counts group_id="E2" events="18" subjects_affected="15" subjects_at_risk="155"/>
                <counts group_id="E3" events="18" subjects_affected="17" subjects_at_risk="154"/>
                <counts group_id="E4" events="21" subjects_affected="19" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Abnormal behaviour</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Aggression</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hallucination</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Parasomnia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Psychotic behaviour</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Psychotic disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Self injurious behaviour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Psychiatric Disorders</sub_title>
                <description>Sum of all adverse event terms in the Psychiatric Disorders System Organ Class</description>
                <counts group_id="E1" events="10" subjects_affected="8" subjects_at_risk="152"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="155"/>
                <counts group_id="E3" events="7" subjects_affected="5" subjects_at_risk="154"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Bladder obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Polyuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Renal and Urinary Disorders</sub_title>
                <description>Sum of all adverse event terms in the Renal and Urinary Disorders System Organ Class</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="154"/>
                <counts group_id="E4" events="6" subjects_affected="6" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Epididymitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Prostatomegaly</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Aspiration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Choking</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" events="8" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E4" events="6" subjects_affected="4" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="3" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pulmonary haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pulmonary thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Respiratory depression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Respiratory Disorders</sub_title>
                <description>Sum of all adverse event terms in the Respiratory Disorders System Organ Class</description>
                <counts group_id="E1" events="12" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E2" events="11" subjects_affected="9" subjects_at_risk="155"/>
                <counts group_id="E3" events="8" subjects_affected="7" subjects_at_risk="154"/>
                <counts group_id="E4" events="17" subjects_affected="11" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Skin Disorders</sub_title>
                <description>Sum of all adverse event terms in the Skin Disorders System Organ Class</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Respite care</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Treatment noncompliance</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Social Circumstances</sub_title>
                <description>Sum of all adverse event terms in the Social Circumstances System Organ Class</description>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Arterial bypass operation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Bladder neoplasm surgery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cardiac operation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker battery replacement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker insertion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker replacement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cholecystectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Coronary arterial stent insertion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Drug detoxification</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hip arthroplasty</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hospice care</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Knee arthroplasty</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Renal stone removal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Spinal laminectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Surgery</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Transurethral prostatectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Surgical and Medical Procedures</sub_title>
                <description>Sum of all adverse event terms in the Surgical and Medical Procedures System Organ Class</description>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="152"/>
                <counts group_id="E2" events="7" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E3" events="6" subjects_affected="5" subjects_at_risk="154"/>
                <counts group_id="E4" events="6" subjects_affected="5" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Aortic disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="4" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Peripheral embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Shock</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Vascular Disorders</sub_title>
                <description>Sum of all adverse event terms in the Vascular Disorders System Organ Class</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="152"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E3" events="9" subjects_affected="6" subjects_at_risk="154"/>
                <counts group_id="E4" events="6" subjects_affected="6" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDra 15.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="91" subjects_at_risk="152"/>
                <counts group_id="E2" subjects_affected="97" subjects_at_risk="155"/>
                <counts group_id="E3" subjects_affected="90" subjects_at_risk="154"/>
                <counts group_id="E4" subjects_affected="89" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Anaemia macrocytic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Haemorrhagic disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Coronary artery insufficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Sick sinus syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Arteriovenous malformation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dermoid cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Hearing impaired</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypoacusis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Vestibular disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Age-related macular degeneration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Blindness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dry eye</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Entropion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Macular degeneration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Refraction disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Retinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="152"/>
                <counts group_id="E2" events="8" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="154"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Eructation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Flatulence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia oral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Oesophageal disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Oral mucosal erythema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Retching</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Small intestinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Device occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Influenza like illness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Irritability</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Xerosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Gallbladder pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Abscess oral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Breast cellulitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cellulitis staphylococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Fungal skin infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Furuncle</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastric infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hordeolum</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Labyrinthitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Lymph gland infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Onychomycosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Orchitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Otitis externa</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Paronychia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection fungal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Tinea cruris</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E3" events="7" subjects_affected="6" subjects_at_risk="154"/>
                <counts group_id="E4" events="3" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accident at home</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Arthropod bite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Drug dose omission</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Drug prescribing error</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Exposure to chemical pollution</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Face injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="58" subjects_affected="31" subjects_at_risk="152"/>
                <counts group_id="E2" events="39" subjects_affected="28" subjects_at_risk="155"/>
                <counts group_id="E3" events="65" subjects_affected="37" subjects_at_risk="154"/>
                <counts group_id="E4" events="48" subjects_affected="31" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>In-stent coronary artery restenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Incorrect dose administered</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Joint injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Blood albumin abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Blood bicarbonate increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Blood cholesterol increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Blood homocysteine increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Blood potassium increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Blood triglycerides increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Blood urea increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Culture negative</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Full blood count increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Glycosylated haemoglobin increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Heart rate decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hepatic enzyme increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>High density lipoprotein increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>International normalised ratio increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Laboratory test abnormal</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="152"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="155"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Prostatic specific antigen increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Failure to thrive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Chondrocalcinosis pyrophosphate</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Exostosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Flank pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Groin pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Joint swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="3" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Synovial cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Acute myeloid leukaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Bladder neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Bone neoplasm malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Lip and/or oral cavity cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Lung neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Neoplasm skin</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Neuroendocrine carcinoma of the skin</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Skin cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of skin</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Altered state of consciousness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Aphasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="152"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="155"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="154"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dizziness postural</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dyskinesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypersomnia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Mental impairment</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Radial nerve palsy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E4" events="4" subjects_affected="3" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Trigeminal neuralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Unresponsive to stimuli</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Visual field defect</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Abnormal behaviour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Abnormal sleep-related event</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Aggression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Alcohol abuse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Apathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Delusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Depressed mood</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Disorientation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hallucination</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Nightmare</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Paranoia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Self injurious behaviour</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Social avoidant behaviour</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Incontinence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Renal artery stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Renal cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Breast discharge</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Prostatomegaly</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Spermatocele</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="4" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Paranasal sinus hypersecretion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Rhinitis seasonal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Sneezing</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Tracheomalacia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dermatitis allergic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dermatitis diaper</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Purpura senile</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Rash pruritic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Skin lesion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Treatment noncompliance</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Arterial bypass operation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Dialysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Emergency care</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Intervertebral disc operation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Medical device removal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Rehabilitation therapy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Stent placement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Tooth extraction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Transurethral prostatectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Labile blood pressure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="155"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="154"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Peter Guarino, PhD, Director WH-CSPCC</name_or_title>
      <organization>Dept. of Veterans Affairs Cooperative Stduies Program</organization>
      <phone>203-932-5711 ext 3780</phone>
      <email>peter.guarino@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

